Correction to Lancet Infect Dis 2021; 21: 823–33

IF 36.4 1区医学 Q1 INFECTIOUS DISEASES

Lancet Infectious Diseases Pub Date : 2024-10-07 DOI:10.1016/s1473-3099(24)00671-6

引用次数: 0

Abstract

Hsu Y-C, Chen C-Y, Chang I-W, et al. Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. Lancet Infect Dis 2021; 21: 823–33—In this Article, I-Wei Chang's affiliation has been corrected. This correction has been made as of Oct 7, 2024.

查看原文本刊更多论文

柳叶刀传染病》2021 年版更正；21: 823-33

Hsu Y-C，Chen C-Y，Chang I-W，et al.每日一次富马酸替诺福韦二吡呋酯治疗对丙氨酸氨基转移酶微升高且无治疗需求的台湾慢性乙型肝炎患者（TORCH-B）：一项多中心、双盲、安慰剂对照、平行组、随机试验。Lancet Infect Dis 2021; 21: 823-33-在本文中，I-Wei Chang 的单位已更正。此更正截至 2024 年 10 月 7 日。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Infectious Diseases 医学-传染病学

CiteScore

60.90

自引率

0.70%

发文量

1064

审稿时长

6-12 weeks

期刊介绍： The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.